JP2002508773A5 - - Google Patents

Download PDF

Info

Publication number
JP2002508773A5
JP2002508773A5 JP1999505984A JP50598499A JP2002508773A5 JP 2002508773 A5 JP2002508773 A5 JP 2002508773A5 JP 1999505984 A JP1999505984 A JP 1999505984A JP 50598499 A JP50598499 A JP 50598499A JP 2002508773 A5 JP2002508773 A5 JP 2002508773A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1999505984A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002508773A (ja
Filing date
Publication date
Priority claimed from BE9700572A external-priority patent/BE1011251A3/fr
Application filed filed Critical
Publication of JP2002508773A publication Critical patent/JP2002508773A/ja
Publication of JP2002508773A5 publication Critical patent/JP2002508773A5/ja
Withdrawn legal-status Critical Current

Links

JP50598499A 1997-07-03 1998-07-02 活性物質及びシクロデキストリンを含有する経口投与用医薬剤 Withdrawn JP2002508773A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BE9700572 1997-07-03
BE9700572A BE1011251A3 (fr) 1997-07-03 1997-07-03 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine.
PCT/BE1998/000100 WO1999001133A1 (fr) 1997-07-03 1998-07-02 Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007004722A Division JP2007091760A (ja) 1997-07-03 2007-01-12 活性物質及びシクロデキストリンを含有する経口投与用医薬剤

Publications (2)

Publication Number Publication Date
JP2002508773A JP2002508773A (ja) 2002-03-19
JP2002508773A5 true JP2002508773A5 (https=) 2006-10-26

Family

ID=3890611

Family Applications (2)

Application Number Title Priority Date Filing Date
JP50598499A Withdrawn JP2002508773A (ja) 1997-07-03 1998-07-02 活性物質及びシクロデキストリンを含有する経口投与用医薬剤
JP2007004722A Pending JP2007091760A (ja) 1997-07-03 2007-01-12 活性物質及びシクロデキストリンを含有する経口投与用医薬剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007004722A Pending JP2007091760A (ja) 1997-07-03 2007-01-12 活性物質及びシクロデキストリンを含有する経口投与用医薬剤

Country Status (20)

Country Link
US (1) US6455533B1 (https=)
EP (1) EP0994710B2 (https=)
JP (2) JP2002508773A (https=)
KR (1) KR100551510B1 (https=)
CN (1) CN1150900C (https=)
AT (1) ATE224717T1 (https=)
AU (1) AU727140B2 (https=)
BE (1) BE1011251A3 (https=)
BR (1) BR9810495A (https=)
CA (1) CA2294783C (https=)
DE (1) DE69808297T3 (https=)
DK (1) DK0994710T4 (https=)
ES (1) ES2184293T5 (https=)
ID (1) ID23806A (https=)
IL (1) IL133397A (https=)
NZ (1) NZ501820A (https=)
PL (1) PL192348B1 (https=)
PT (1) PT994710E (https=)
RU (1) RU2192863C2 (https=)
WO (1) WO1999001133A1 (https=)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
KR20030094244A (ko) * 2001-02-05 2003-12-11 알.피.쉐러 테크놀러지즈 인코포레이티드 약리학적 활성제의 맛을 감소시키기 위한 방법 및 조성물
PL212123B1 (pl) * 2002-01-15 2012-08-31 Ucb Farchim Sa Doustna kompozycja farmaceutyczna
WO2003084511A1 (en) * 2002-04-04 2003-10-16 Pfizer Products Inc. Palatable chewable tablet
EP1771161B1 (en) * 2004-07-22 2010-04-21 Bend Research, Inc Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form
US20060147518A1 (en) * 2004-12-30 2006-07-06 Pierre Fabre Medicament Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
US20070086974A1 (en) * 2005-10-06 2007-04-19 Gawande Rahul S Cetirizine compositions
WO2007144902A1 (en) * 2006-06-12 2007-12-21 Jubliant Organosys Limited Chewable bilayer tablet formulation
JP2008143807A (ja) * 2006-12-07 2008-06-26 Sato Pharmaceutical Co Ltd 感冒薬カプセル剤及びその製造方法
EP2550967A1 (en) * 2007-07-11 2013-01-30 Fertin Pharma A/S Compressed chewing gum tablet comprising taste-masking agent
EP2178521B1 (en) * 2007-07-11 2014-01-15 Fertin Pharma A/S Stable medicated chewing gum comprising cyclodextrin inclusion complex
WO2009054432A1 (ja) * 2007-10-26 2009-04-30 Daiichi Sankyo Company, Limited 口腔内速崩壊性医薬組成物およびその製造方法
US8138192B2 (en) * 2007-10-31 2012-03-20 Genebiology, Inc. Injectable meclizine formulations and methods
EP2067469A1 (en) 2007-11-06 2009-06-10 Teva Pharmaceutical Industries Ltd. Chewable formulations
CN102143737A (zh) * 2008-09-05 2011-08-03 麦克内尔-Ppc股份有限公司 制备西替利嗪片剂的方法
DK2468281T3 (en) 2009-08-19 2016-03-21 Eisai R&D Man Co Ltd Quinolinderivatholdig pharmaceutical composition
WO2011110939A2 (en) * 2010-03-11 2011-09-15 Rubicon Research Private Limited Pharmaceutical compositions of substituted benzhydrylpiperazines
HK1161509A2 (en) * 2010-06-04 2012-07-27 全球药物科技有限公司 Oral meclizine aqueous formulations with taste flavoring agent
CN101905027A (zh) * 2010-07-27 2010-12-08 北京华禧联合科技发展有限公司 含米格列奈钙和环糊精的口服药用组合物
WO2012037117A1 (en) 2010-09-13 2012-03-22 Bev-Rx, Inc. Aqueous drug delivery system comprising off - flavor masking agent
JP6038128B2 (ja) 2011-06-03 2016-12-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 レンバチニブ化合物に対する甲状腺癌対象及び腎臓癌対象の反応性を予測及び評価するためのバイオマーカー
RU2589833C2 (ru) * 2013-12-12 2016-07-10 Общество С Ограниченной Ответственностью "Фарма Старт" Твердая лекарственная форма препарата седативного и снотворного действия
PT3122330T (pt) * 2014-03-27 2018-11-13 Ucb Farchim Sa Composições farmacêuticas compreendendo levocetirizina
PT3524595T (pt) 2014-08-28 2022-09-19 Eisai R&D Man Co Ltd Derivado de quinolina altamente puro e método para produção do mesmo
AU2016224583B2 (en) 2015-02-25 2021-06-03 Eisai R&D Management Co., Ltd. Method for suppressing bitterness of quinoline derivative
KR102662228B1 (ko) 2015-03-04 2024-05-02 머크 샤프 앤드 돔 코포레이션 암을 치료하기 위한 pd-1 길항제 및 vegfr/fgfr/ret 티로신 키나제 억제제의 조합
BR112017027227B1 (pt) 2015-06-16 2023-12-12 Eisai R&D Management Co., Ltd Agente anti-câncer
JP6553726B2 (ja) 2015-08-20 2019-07-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍治療剤
JP6581320B2 (ja) 2017-02-08 2019-09-25 エーザイ・アール・アンド・ディー・マネジメント株式会社 腫瘍治療用医薬組成物
EP3624800A4 (en) 2017-05-16 2021-02-17 Eisai R&D Management Co., Ltd. TREATMENT OF HEPATOCELLULAR CARCINOMA
KR102110304B1 (ko) * 2017-06-30 2020-05-14 한미약품 주식회사 레보세티리진 및 몬테루카스트를 포함하는 안정성 및 복약순응도가 향상된 복합 츄어블정 및 그 제조방법
AU2021217209A1 (en) * 2020-02-03 2022-09-29 Kenvue Brands Llc A single layer chewable tablet comprising cetirizine
EP4247331B1 (en) 2020-11-18 2025-10-08 BioPharma Synergies, S. L. Orodispersible powder composition comprising an antihistamine compound

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154078C (da) * 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
JPS58177949A (ja) * 1982-04-12 1983-10-18 Takeda Chem Ind Ltd ランカシジン群抗生物質包接化合物
JPS60204712A (ja) * 1984-03-29 1985-10-16 Ss Pharmaceut Co Ltd 塩酸メクリジンの安定化液状組成物
JPS63243031A (ja) 1987-03-28 1988-10-07 Tokyo Tanabe Co Ltd 胆汁酸の固形製剤
US5206025A (en) * 1989-05-24 1993-04-27 Rhone-Poulenc Sante Porous pharmaceutical form and its preparation
FR2647343B1 (fr) 1989-05-24 1994-05-06 Rhone Poulenc Sante Nouvelle forme pharmaceutique poreuse et sa preparation
DE10199031I2 (de) 1992-09-24 2004-09-23 Sepracor Inc Verwendung von (-) Cetrizin zur Behandlung allergischer Rhinitis und Asthma.
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
JPH09509143A (ja) * 1993-12-01 1997-09-16 ビイク グルデン ロンベルク ヒェーミッシェ ファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換アミノアルキルアミノピリジン
US5866179A (en) 1996-05-03 1999-02-02 Avant-Garde Technologies & Products S.A. Medicated chewing gum and a process for preparation thereof
GB0028575D0 (en) * 2000-11-23 2001-01-10 Elan Corp Plc Oral pharmaceutical compositions containing cyclodextrins
EP1771161B1 (en) * 2004-07-22 2010-04-21 Bend Research, Inc Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form

Similar Documents

Publication Publication Date Title
JP2000509635A5 (https=)
JP2002511841A5 (https=)
JP2000509637A5 (https=)
JP2002514117A5 (https=)
JP2001507518A5 (https=)
JP2000509587A5 (https=)
JP2000507369A5 (https=)
JP2000507433A5 (https=)
JP2001505753A5 (https=)
JP2001511149A5 (https=)
JP2000508866A5 (https=)
JP2002503179A5 (https=)
JP2000510793A5 (https=)
JP2000508022A5 (https=)
JP2000508841A5 (https=)
JP2002508773A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509755A5 (https=)
JP2000510969A5 (https=)
JP2000508102A5 (https=)
JP2000508836A5 (https=)
JP2000509818A5 (https=)
JP2000509520A5 (https=)
JP2000507434A5 (https=)